Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
115.00    -2.50 (-2.13%)
Bid:
113.00
Ask:
115.00
Spread: 2.00 (1.77%)
Market Cap: £90.24m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Statement re Xaar plc

14 Nov 2006 16:39

Danaher Corporation14 November 2006 Xaar plc Approach by Danaher Corporation Danaher notes the announcement today by Xaar plc. Danaher confirms that it madean approach to Xaar plc on 13 October 2006 with a proposed all cash offer at aprice of 200 to 220 pence per ordinary share, subject, inter alia, to a numberof waiveable preconditions including due diligence. This proposed offer rangerepresents a premium of circa 32% to circa 45% to Xaar's simple average closingprice over the past three months and circa 24% to circa 36% premium toyesterday's closing price. The Board of Xaar plc has declined to allow Danaheraccess to due diligence and has rejected the approach. Danaher is consideringits position. Neither this announcement nor Danaher's approach to Xaar plc constitute an offeror impose any obligation to make an offer for all or any part of the sharecapital of Xaar plc and, in particular, do not constitute, nor does Danahercurrently have, a firm intention to make an offer for the purposes of Rule 2.5of the Takeover Code. There can be no certainty that any offer will ultimatelybe made even if the preconditions are satisfied or waived. Enquiries Aidan Clegg, UBS Investment Bank+ 44 20 7567-8000 Dealing Disclosure Requirements Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if anyperson is, or becomes, "interested" (directly or indirectly) in 1% or more ofany class of "relevant securities" of Xaar plc, all "dealings" in any "relevantsecurities" of Xaar plc (including by means of an option in respect of, or aderivative referenced to, any such "relevant securities") must be publiclydisclosed by no later than 3.30 pm (London time) on the London business dayfollowing the date of the relevant transaction. This requirement will continueuntil the date on which the offer becomes, or is declared, unconditional as toacceptances, lapses or is otherwise withdrawn or on which the "offer period"otherwise ends. If two or more persons act together pursuant to an agreement orunderstanding, whether formal or informal, to acquire an "interest" in "relevantsecurities" of Xaar plc, they will be deemed to be a single person for thepurpose of Rule 8.3. Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevantsecurities" of Xaar plc by Danaher or Xaar plc or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on theLondon business day following the date of the relevant transaction. A disclosure table, giving details of the companies in whose "relevantsecurities" "dealings" should be disclosed, and the number of such securities inissue, can be found on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary, when a person has long economicexposure, whether conditional or absolute, to changes in the price ofsecurities. In particular, a person will be treated as having an "interest" byvirtue of the ownership or control of securities, or by virtue of any option inrespect of, or derivative referenced to, securities. Terms in quotation marks are defined in the Code, which can also be found on thePanel's website. If you are in any doubt as to whether or not you are requiredto disclose a "dealing" under Rule 8, you should consult the Panel. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Mar 20077:00 amRNSDirector/PDMR Shareholding
21st Mar 20077:00 amRNSHolding(s) in Company
20th Mar 20071:38 pmRNSHolding(s) in Company
19th Mar 20074:02 pmRNSHolding(s) in Company
15th Mar 200711:29 amRNSDividend Record Date Amendmnt
15th Mar 20077:01 amRNSFinal Results
6th Mar 20076:30 pmRNSHolding(s) in Company
15th Feb 20077:01 amRNSNotice of Final Results
14th Feb 20077:01 amRNSOffer Talks Terminated
12th Feb 20076:22 pmRNSHolding(s) in Company
9th Feb 200712:02 pmRNSEPT Disclosure
9th Feb 200710:14 amRNSRule 8.3- Xaar PLC
8th Feb 200711:53 amRNSRule 8.3- Xaar PLC
7th Feb 200711:20 amRNSEPT Disclosure
5th Feb 200710:56 amRNSEPT Disclosure
2nd Feb 200712:12 pmRNSEPT Disclosure
2nd Feb 200710:35 amRNSRule 8.3- Xaar PLC
31st Jan 200712:38 pmRNSRule 8.3- Xaar PLC
31st Jan 200712:02 pmRNSRule 8.3- Xaar PLC
30th Jan 20071:07 pmPRNRule 8.3 - XAAR PLC
30th Jan 200710:48 amRNSRule 8.3- Xaar PLC
29th Jan 20079:46 amRNSRule 8.3- Xaar PLC
25th Jan 200710:32 amRNSEPT Disclosure
25th Jan 200710:21 amRNSRule 8.3- Xaar PLC
24th Jan 200710:06 amRNSRule 8.3- Xaar PLC
23rd Jan 20079:19 amRNSRule 8.3- Xaar PLC
22nd Jan 200711:32 amRNSRule 8.3- Xaar PLC
19th Jan 20079:45 amRNSRule 8.3- Xaar
17th Jan 200711:54 amRNSEPT Disclosure
16th Jan 200711:48 amRNSEPT Disclosure
16th Jan 20079:52 amRNSRule 8.3- Xaar PLC
15th Jan 200711:01 amRNSRule 8.3- Xaar PLC
12th Jan 200710:30 amRNSEPT Disclosure
29th Dec 20069:20 amRNSAdditional Listing
28th Dec 200611:46 amRNSEPT Disclosure
28th Dec 20068:50 amRNSAdditional Listing
27th Dec 20069:03 amRNSAdditional Listing
22nd Dec 20068:32 amRNSAdditional Listing
21st Dec 200612:28 pmRNSEPT Disclosure
21st Dec 200610:30 amRNSAdditional Listing
21st Dec 200610:29 amRNSAdditional Listing
20th Dec 20064:22 pmRNSHolding(s) in Company
19th Dec 200612:21 pmRNSTotal Voting Rights
19th Dec 200612:02 pmRNSEPT Disclosure
18th Dec 20061:34 pmRNSEPT Disclosure
18th Dec 20061:07 pmRNSRule 8.3- Xaar PLC
15th Dec 200612:45 pmRNSEPT Disclosure
12th Dec 20061:02 pmRNSEPT Disclosure
11th Dec 200611:52 amPRNRule 8.3
8th Dec 200612:29 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.